Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ferrara, R.
Right arrow Articles by Ferrari, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ferrara, R.
Right arrow Articles by Ferrari, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Myocardial metabolism: the diabetic heart

R. Ferrara, G. Guardigli and R. Ferrari*

University of Ferrara, Ferrara, and Centre of Cardiovascular Research, Fondazione Salvatore Maugeri, Gussago, Italy

* Professor Roberto Ferrari, Chair of Cardiology, University of Ferrara, Corso Giovecca 203, 44100 Ferrara, Italy.

Abstract

The prevalence of type 2 diabetes mellitus is rapidly increasing, and with it the risk for cardiovascular events. Diabetic patients with cardiovascular disease have a very unfavourable prognosis and their management remains a challenge, despite recent progress with angiotensin-converting enzyme inhibitors and statins. Metabolic factors associated with diabetic status are of critical importance, both for the myocardium and for the vascular system in general. An important effect of diabetes that impacts on cardiac function is the switch from carbohydrate to free fatty acid oxidation. Correction of the alterations in cardiac metabolism associated with diabetes may represent a new approach to the management of ischaemic heart disease. Results obtained with trimetazidine and ranolazine in patients with angina pectoris are consistent with this hypothesis. Evidence for the beneficial effects of meticulous insulin-based glycaemic control in patients with acute myocardial infarction also suggests an important role for metabolic therapy. More knowledge on the metabolism of diabetic patients, and active collaboration between endocrinologists and cardiologists are essential if we are to achieve further success in managing diabetic patients who are at risk for cardiovascular disease. The present reviews addresses current information on the metabolism of the diabetic heart.

Key Words: Cardiac metabolism • coronary artery disease • diabetes mellitus • risk factors

References

  1. Kannel WB, McGee DL. Diabetes and glucose tolerance as a risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2:120–126[Abstract]
  2. Howard BV, Cowan LD, Go O, et al. adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the Strong Heart Study. Diabetes Care. 1998;21:1258–1265[Abstract]
  3. Keaney JF Jr, Loscalzo J. Diabetes, oxidative stress, and platelet activation. Circulation. 1999;99:189–191[Free Full Text]
  4. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycaemia attenuate endothelium-dependent in humans in vivo. Circulation. 1998;97:1695–1701[Abstract/Free Full Text]
  5. Laakso M. Hyperglycaemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48:937–942[Abstract]
  6. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126[Free Full Text]
  7. Moreno PR, Murcia AM, Palacios IF, et al. Coronary composition and macrophages infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation. 2000;102:2180–2184[Abstract/Free Full Text]
  8. Kannel WB. Lipid, diabetes and coronary artery disease: insight from the Framingham study. Am Heart J. 1985;110:1100–1107[CrossRef][Web of Science][Medline]
  9. Syvanne M, Taskinen M-R. Lipids and lipoproteins as coronary risk factors in non insulin-dependent diabetes mellitus. Lancet. 1997;350(suppl 1):20–23[CrossRef]
  10. Jokel R, Colwell JA. Arterial thrombosis in atherosclerosis in diabetes. Diabetes Rev. 1997;5:316–330
  11. Van Wersch JWJ, Westerhuis LWJJM, Venekamp WJRR. Coagulation activation in diabetes mellitus. Haemostasis. 1990;20:263–269[Medline]
  12. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res. 1997;34:25–33[Free Full Text]
  13. Shapiro LM, Howat AP, Calter MN. Left ventricular function in diabetes mellitus. Methodology and prevalence and spectrum of abnormalities. Br Heart J. 1991;45:122–128
  14. Kannel WB, Hiortland M, Castellu WP. Role of diabetes in congestive heart failure: the Framingham Heart Study. Am J Cardiol. 1974;34:29–34[CrossRef][Web of Science][Medline]
  15. Marzilli M. Management of ischaemic heart disease in diabetic patients. Is there a role for cardiac metabolic agents? Curr Med Res Opin. 2001;17:153–158[Medline]
  16. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium (GIK) therapy for treatment of acute myocardial infarction: an overview of randomized placebo controlled trials. Circulation. 1997;96:1152–1156[Abstract/Free Full Text]
  17. Lopaschuk GD. Optimising cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated? Coron Artery Dis. 2001;12(suppl 1):S8–S11
  18. Kantor PF, Luvien A, KozaK R, Lopaschuk GD. The anginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long chain 2-ketoacyl coenzyme A thiolase. Circ Res. 2000;86:580–588[Abstract/Free Full Text]
  19. Szwed H, Pachoki R, Domnzal-Bochenska M. The anti-ischaemic effect and tolerability of trimetazidine in coronary diabetic patients. A sub-study from Trimpol-1. Cardiovasc Drugs Ther. 1999;13:215–220

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ferrara, R.
Right arrow Articles by Ferrari, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ferrara, R.
Right arrow Articles by Ferrari, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?